These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 494411)

  • 21. [Clinical aspects and treatment of paroxysmal forms of cardiac rhythm disorders].
    Vasilenko VKh; Golochevskaĭa VS; Fomina IG
    Ter Arkh; 1973 Dec; 45(12):46-55. PubMed ID: 4779666
    [No Abstract]   [Full Text] [Related]  

  • 22. [Oral administration of N-propyl-ajmaline bitartrate in heart rhythm disorders].
    Böttcher D; Nissen P; Harmjanz D
    Med Klin; 1972 Jun; 67(24):855-9. PubMed ID: 4116006
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ajmaline bitartrate in arrhythmias].
    Szoenberg A; Samuel R; Friedman J; Sklerovsky S
    Harefuah; 1974 Jan; 86(2):70-5. PubMed ID: 4133115
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of prajmalium bitartrate in the treatment of hyperkinetic ventricular arrhythmias].
    Speziali B; Gandolfo N; Parigi A
    Minerva Cardioangiol; 1986 Jun; 34(6):421-9. PubMed ID: 3762985
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adverse effects of recent ventricular anti-arrhythmia drug].
    Raynaud R; Brochier M; Fauchier JP; Raynaud P
    Vie Med Can Fr; 1972 Feb; 1(2):127-39. PubMed ID: 4637391
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modification by lidocain and other anti-arrhythmia agents on the combination of fixed and variably coupled ectopic ventricular beats].
    Burkhardt D; Steinbrunn W; Kaufmann G
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1787-9. PubMed ID: 4768697
    [No Abstract]   [Full Text] [Related]  

  • 27. [On ajmaline treatment of heart rhythm disorders].
    Forster G; Holzmann M
    Schweiz Med Wochenschr; 1967 Feb; 97(6):185-93 contd. PubMed ID: 4174226
    [No Abstract]   [Full Text] [Related]  

  • 28. [The antiarrhythmic effect of intravenous 17-monochloroacetyl-ajmaline. A review of 50 treated cases].
    Fiol Sala M
    Med Clin (Barc); 1983 Jun; 81(3):105-8. PubMed ID: 6888063
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of the ajmaline test. Apropos of 1170 cases].
    Perrot B; Aliot E; Gilgenkrantz JM; Cherrier F; Faivre G
    Ann Cardiol Angeiol (Paris); 1982; 31(6):435-41. PubMed ID: 7158990
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of the class IA anti-arrhythmic agents ajmaline on end-systolic pressure-volume relations (conductance technique)].
    Thormann J; Hüting J; Kremer P; Mitrovic V; Wissemann J; Bahawar H; Schlepper M
    Z Kardiol; 1990 Oct; 79(10):706-16. PubMed ID: 2087858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of PGF2 alpha on experimental arrhythmias.
    Förster W; Mest HJ; Mentz P
    Prostaglandins; 1973 Jun; 3(6):895-904. PubMed ID: 4729607
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preventive treatment of arrhythmias with di-monochloroacetyl-ajmaline (DCAA)].
    Mancuso M; Salazzari GC; Cicogna F; Zanini S
    Minerva Cardioangiol; 1973; 21(7):513-20. PubMed ID: 4756346
    [No Abstract]   [Full Text] [Related]  

  • 33. [Electrophysiological effects of ajmaline on the human conduction system (author's transl)].
    Alboni P; Malacarne E; Pedroni P
    G Ital Cardiol; 1978; 8(7):752-63. PubMed ID: 680433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study of the effects of creatinolo-O-phosphate on the electrical activity of the rat heart].
    Mei V; Bruno C; Valora N
    Boll Soc Ital Biol Sper; 1974 Feb; 50(4):168-73. PubMed ID: 4447710
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ventricular flutter due to the treatment with novocainamid and strophanthin].
    Vasil'eva VL; Grinberg GI; Iankin VV; Fomina IG
    Klin Med (Mosk); 1979 Nov; 57(11):96-8. PubMed ID: 544918
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral prevention of heart infarct following arrhythmias with Neo-Gilurytmal].
    Wenger R; Madera F
    ZFA (Stuttgart); 1977 Jan; 53(1):33-4. PubMed ID: 842099
    [No Abstract]   [Full Text] [Related]  

  • 37. [Jaundice caused by ajmaline: pathogenetic theory concerning 5 cases].
    Giani E; Cestari C; Lomazzi A; Magni S; Pioltelli P; Ratti L; Dinelli CA
    Clin Ter; 1981 Oct; 99(2):155-64. PubMed ID: 7318369
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of ajmaline in experimental and clinical arrhythmias and their relation to some electrophysiological parameters of the heart.
    Bojorges R; Pastelin G; Sanchez-Perez S; Mendez R; Kabela E
    J Pharmacol Exp Ther; 1975 Apr; 193(1):182-93. PubMed ID: 1133763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Asystole followed by cardiogenic shock after intravenous injection of verapamil].
    Motté G; Bellanger P; Vogel M; Belhassen B; Welti JJ
    Ann Cardiol Angeiol (Paris); 1975; 24(2):157-62. PubMed ID: 1094900
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and experimental studies on the effects and duration of action of N-n-propyl-ajmalinium-hydrogentartrate in cardiac arrhythmia].
    Koch R
    Arzneimittelforschung; 1972 Dec; 22(12):2079-84. PubMed ID: 4679174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.